Cargando…
Efficacy and safety of mycophenolate mofetil for IgA nephropathy: An updated meta-analysis of randomized controlled trials
The efficacy and safety of mycophenolate mofetil (MMF) for immunoglobulin A nephropathy (IgAN) remains debatable. Therefore, the present meta-analysis was conducted with randomized controlled trials (RCTs). PubMed/MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials were analyzed t...
Autores principales: | Zheng, Jian-Nan, Bi, Tong-Dan, Zhu, Lin-Bo, Liu, Lin-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122311/ https://www.ncbi.nlm.nih.gov/pubmed/30186414 http://dx.doi.org/10.3892/etm.2018.6418 |
Ejemplares similares
-
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
por: Du, Bing, et al.
Publicado: (2017) -
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
por: Chen, Youyuan, et al.
Publicado: (2014) -
Mycophenolate Mofetil for Severe IgA Vasculitis Nephropathy in Children: An Observational Study
por: Samsonov, Dmitry, et al.
Publicado: (2022) -
Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015) -
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
por: Hogg, Ronald J, et al.
Publicado: (2004)